CorMedix (CRMD) Interest Expenses (2012 - 2025)

CorMedix (CRMD) has 14 years of Interest Expenses data on file, last reported at $2.6 million in Q4 2025.

• For the quarter ending Q4 2025, Interest Expenses rose 2296.21% year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2025 stood at $2.5 million (up 26715.41% YoY), and the FY2025 full-year result was $113.3 million, up 380.86% from the prior year.
• Interest Expenses slipped to $2.6 million in Q4 2025, from $280.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $280.0 million in Q3 2025 to a low of -$116986.0 in Q4 2024.
• A 5-year average of $15.1 million and a median of $169000.0 in 2024 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses tumbled 1884.41% in 2024 and jumped 548919.61% in 2025, its largest moves.
• Tracing CRMD's Interest Expenses over 5 years: stood at $5378.0 in 2021, then soared by 3270.4% to $181260.0 in 2022, then slumped by 96.38% to $6556.0 in 2023, then plunged by 1884.41% to -$116986.0 in 2024, then soared by 2296.21% to $2.6 million in 2025.
• Business Quant data shows CRMD's Interest Expenses at $2.6 million in Q4 2025, $280.0 million in Q3 2025, and $2.4 million in Q2 2025.